181 related articles for article (PubMed ID: 26844874)
1. Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease.
Lochhead P; Khalili H; Ananthakrishnan AN; Richter JM; Chan AT
Clin Gastroenterol Hepatol; 2016 Jun; 14(6):818-824.e6. PubMed ID: 26844874
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of perfluoroalkyl substances and risk of inflammatory bowel diseases in women: A nested case control analysis in the Nurses' Health Study cohorts.
Lochhead P; Khalili H; Ananthakrishnan AN; Burke KE; Richter JM; Sun Q; Grandjean P; Chan AT
Environ Res; 2022 May; 207():112222. PubMed ID: 34662575
[TBL] [Abstract][Full Text] [Related]
3. Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts.
Khalili H; Ananthakrishnan AN; Konijeti GG; Higuchi LM; Fuchs CS; Richter JM; Tworoger SS; Hankinson SE; Chan AT
Inflamm Bowel Dis; 2015 Jun; 21(6):1378-85. PubMed ID: 25844961
[TBL] [Abstract][Full Text] [Related]
4. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
5. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
[TBL] [Abstract][Full Text] [Related]
7. Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women.
Li WQ; Cho E; Khalili H; Wu S; Chan AT; Qureshi AA
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):220-5.e1-3. PubMed ID: 26404866
[TBL] [Abstract][Full Text] [Related]
8. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia.
Ng SC; Zeng Z; Niewiadomski O; Tang W; Bell S; Kamm MA; Hu P; de Silva HJ; Niriella MA; Udara WS; Ong D; Ling KL; Ooi CJ; Hilmi I; Lee Goh K; Ouyang Q; Wang YF; Wu K; Wang X; Pisespongsa P; Manatsathit S; Aniwan S; Limsrivilai J; Gunawan J; Simadibrata M; Abdullah M; Tsang SW; Lo FH; Hui AJ; Chow CM; Yu HH; Li MF; Ng KK; Ching JY; Chan V; Wu JC; Chan FK; Chen M; Sung JJ;
Gastroenterology; 2016 Jan; 150(1):86-95.e3; quiz e13-4. PubMed ID: 26385074
[TBL] [Abstract][Full Text] [Related]
9. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
[TBL] [Abstract][Full Text] [Related]
11. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
12. Association Between Statin Use and Inflammatory Bowel Diseases: Results from a Swedish, Nationwide, Population-based Case-control Study.
Lochhead P; Khalili H; Sachs MC; Chan AT; Olén O; Ludvigsson JF
J Crohns Colitis; 2021 May; 15(5):757-765. PubMed ID: 33216873
[TBL] [Abstract][Full Text] [Related]
13. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.
Niewiadomski O; Studd C; Hair C; Wilson J; Ding NS; Heerasing N; Ting A; McNeill J; Knight R; Santamaria J; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Popp B; Connell W; Desmond P; Bell S
J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770
[TBL] [Abstract][Full Text] [Related]
14. Inverse Association Between Poor Oral Health and Inflammatory Bowel Diseases.
Yin W; Ludvigsson JF; Liu Z; Roosaar A; Axéll T; Ye W
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):525-531. PubMed ID: 27392757
[TBL] [Abstract][Full Text] [Related]
15. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.
Ng SC; Tang W; Ching JY; Wong M; Chow CM; Hui AJ; Wong TC; Leung VK; Tsang SW; Yu HH; Li MF; Ng KK; Kamm MA; Studd C; Bell S; Leong R; de Silva HJ; Kasturiratne A; Mufeena MNF; Ling KL; Ooi CJ; Tan PS; Ong D; Goh KL; Hilmi I; Pisespongsa P; Manatsathit S; Rerknimitr R; Aniwan S; Wang YF; Ouyang Q; Zeng Z; Zhu Z; Chen MH; Hu PJ; Wu K; Wang X; Simadibrata M; Abdullah M; Wu JC; Sung JJY; Chan FKL;
Gastroenterology; 2013 Jul; 145(1):158-165.e2. PubMed ID: 23583432
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein as a diagnostic and prognostic factor in inflammatory bowel diseases.
Mańkowska-Wierzbicka D; Karczewski J; Poniedziałek B; Grzymisławska M; Staszewski R; Królczyk A; Dobrowolska A; Grzymisławski M
Postepy Hig Med Dosw (Online); 2016 Nov; 70(0):1124-1130. PubMed ID: 27892896
[TBL] [Abstract][Full Text] [Related]
17. Dietary Gluten Intake Is Not Associated With Risk of Inflammatory Bowel Disease in US Adults Without Celiac Disease.
Lopes EW; Lebwohl B; Burke KE; Ivey KL; Ananthakrishnan AN; Lochhead P; Richter JM; Ludvigsson JF; Willett WC; Chan AT; Khalili H
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):303-313.e6. PubMed ID: 33775898
[TBL] [Abstract][Full Text] [Related]
18. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
19. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
